Position in ATRA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$827
-$2,338 QoQ
Shares Held
175
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ATRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ATRA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $827 | 175 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,165 | 175 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,507 | 175 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,351 | 175 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,039 | 175 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,329 | 175 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,422 | 175 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,797 | 682 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $102,416 | 147,574 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $74,596 | 145,413 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $215,300 | 145,473 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $229,864 | 142,773 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $427,378 | 147,372 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $469,226 | 143,057 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $535,644 | 141,705 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,084,251 | 139,185 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,108,798 | 119,354 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,018,682 | 128,089 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,256,062 | 126,037 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,975,378 | 127,034 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,667,669 | 116,133 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,405,558 | 122,545 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,388,845 | 107,164 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,546,095 | 106,115 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $627,714 | 73,762 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||